+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Sulfonylureas"

From
From
From
Type 2 Diabetes Market Report 2025 - Product Thumbnail Image

Type 2 Diabetes Market Report 2025

  • Report
  • March 2025
  • 200 Pages
  • Global
From
From
Type 2 Diabetes - Pipeline Insight, 2024 - Product Thumbnail Image

Type 2 Diabetes - Pipeline Insight, 2024

  • Drug Pipelines
  • November 2024
  • 240 Pages
  • Global
From
Type 2 Diabetes Pipeline Analysis Report - Product Thumbnail Image

Type 2 Diabetes Pipeline Analysis Report

  • Report
  • August 2024
  • 150 Pages
  • Global
From
From
From
From
Diabetes Care Drugs Market - Forecasts from 2022 to 2027 - Product Thumbnail Image

Diabetes Care Drugs Market - Forecasts from 2022 to 2027

  • Report
  • October 2022
  • 138 Pages
  • Global
From
Dementia with Diabetes - Pipeline Insight, 2024 - Product Thumbnail Image

Dementia with Diabetes - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 40 Pages
  • Global
From
Type 2 Diabetes Market Report and Forecast 2024-2032 - Product Thumbnail Image

Type 2 Diabetes Market Report and Forecast 2024-2032

  • Report
  • November 2023
  • 160 Pages
  • Global
From
Diabetes Drugs Market Report and Forecast 2023-2031 - Product Thumbnail Image

Diabetes Drugs Market Report and Forecast 2023-2031

  • Report
  • May 2023
  • 147 Pages
  • Global
From
Anti-diabetic Drugs Market - Product Thumbnail Image

Anti-diabetic Drugs Market

  • Report
  • January 2024
  • 200 Pages
  • Global
From
From
From
From
Loading Indicator

Sulfonylureas are a class of drugs used to treat type 2 diabetes. They work by stimulating the pancreas to produce more insulin, which helps the body to better process glucose. They are usually taken orally, and are often used in combination with other diabetes medications. Sulfonylureas are generally well-tolerated, but can cause side effects such as hypoglycemia, weight gain, and gastrointestinal upset. The sulfonylureas market is a subset of the larger diabetes drugs market. It is a competitive market, with a range of products available from different manufacturers. The market is expected to grow in the coming years, driven by increasing prevalence of diabetes and the development of new drugs. Some of the major companies in the sulfonylureas market include Novo Nordisk, Sanofi, Eli Lilly, Merck, and Boehringer Ingelheim. Show Less Read more